查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1592003

體外診斷藥品包裝市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

In-Vitro Diagnostics Packaging Market by Product (Bottles, Closures, Tubes), End User (Academic Institutes, Clinical Laboratories, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年體外診斷包裝市場規模為72.4億美元，預計2024年將達77億美元，複合年成長率為6.75%，預計到2030年將達到114.4億美元。

體外診斷（IVD）包裝市場是指體外診斷領域產品所需的專業包裝解決方案，例如用於診斷和監測健康狀況的試劑、儀器和檢測套組。範圍和定義涵蓋了確保診斷組件（例如管瓶、管子、瓶子和瓶蓋）的安全性、穩定性和無菌性的包裝類型。嚴格的監管標準推動了對堅固 IVD 包裝的需求，這些標準確保產品完整性、防止污染並滿足運輸溫度敏感診斷的複雜物流需求。從應用來看，這些包裝解決方案對於醫院、實驗室和診所至關重要，最終用途包括病理實驗室、研究機構和學術部門。關鍵的成長要素包括慢性病和感染疾病的流行、對就地檢驗的需求不斷增加以及個人化醫療的進步。機會比比皆是，包括向永續和環保包裝材料的轉變，以及對增強產品追蹤和用戶參與度的智慧包裝等創新解決方案的需求不斷成長。然而，嚴格的監管要求和與創新封裝技術相關的高成本構成了重大的市場挑戰。此外，隨著世界各地醫療保健系統的價格壓力持續增加，對具有成本效益的包裝解決方案的需求仍然是關鍵限制因素。潛在的創新領域包括開發結合物聯網和 RFID 技術的智慧包裝，以提高供應鏈效率、增強防篡改功能以及符合全球永續性目標的材料可回收性和提高的生物分解性。為了在這個充滿活力的市場中取得成功，參與者必須專注於策略聯盟和持續研發，以開發適應體外診斷行業不斷變化的需求的適應性強且合規的包裝解決方案。徹底的市場研究提供競爭考察，讓您隨時了解客戶偏好和技術進步，並幫助您適應創新主導但高度監管的市場的本質。

主要市場統計
基準年[2023] 72.4億美元
預測年份 [2024] 77億美元
預測年份 [2030] 114.4億美元
複合年成長率（%） 6.75%

市場動態：快速發展的體外診斷包裝市場的關鍵市場洞察

供需的動態交互作用正在改變體外診斷包裝市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病和感染疾病的盛行率
    • 就地檢驗的成長趨勢
    • 個性化醫療的趨勢
  • 市場限制因素
    • 體外診斷藥物包裝的製造成本高
  • 市場機會
    • 體外診斷智慧包裝簡介
    • 持續研究和開發永續體外診斷包裝的生產
  • 市場挑戰
    • 體外診斷包裝設計的複雜性

波特五力：駕馭體外診斷包裝市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解體外診斷藥品包裝市場的外部影響

外部宏觀環境因素在塑造體外診斷藥物包裝市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解體外診斷藥物包裝市場的競爭狀況

對體外診斷藥品包裝市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣體外診斷藥物包裝市場供應商績效評估

FPNV 定位矩陣是評估體外診斷藥品包裝市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了體外診斷藥品包裝市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，體外診斷藥品包裝市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病及感染疾病率增加
      • 就地檢驗的成長趨勢
      • 個性化醫療方法的趨勢
    • 抑制因素
      • 體外診斷包裝的生產成本較高。
    • 機會
      • 體外診斷智慧包裝簡介
      • 持續研究和開發永續的體外診斷包裝製造
    • 任務
      • 體外診斷包裝設計的複雜性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章體外診斷藥物包裝市場：依產品

  • 瓶子
  • 關閉
  • 管子
  • 管瓶

第7章體外診斷藥品包裝市場：依最終用戶分類

  • 學術機構
  • 臨床實驗室
  • 醫院

第8章 北美、南美洲體外診斷藥物包裝市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太體外診斷藥品包裝市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲體外診斷藥物包裝市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amcor PLC
  • APTARGROUP, INC.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • DWK Life Sciences LLC
  • James Alexander Corporation
  • Narang Medical Limited
  • Oliver-Tolas Healthcare Packaging BV
  • PerkinElmer Inc.
  • PMMI Media Group
  • QIAGEN NV
  • Siemens AG
  • SONIC PACKAGING
  • Thermofisher Scientific Inc.
  • VITLAB GmbH
Product Code: MRR-F6513A06BD97

The In-Vitro Diagnostics Packaging Market was valued at USD 7.24 billion in 2023, expected to reach USD 7.70 billion in 2024, and is projected to grow at a CAGR of 6.75%, to USD 11.44 billion by 2030.

The In-Vitro Diagnostics (IVD) Packaging market refers to the specialized packaging solutions required for products in the in-vitro diagnostics sector, including reagents, instruments, and testing kits used in the diagnosis and monitoring of health conditions. Scope and definition cover packaging types such as vials, tubes, bottles, and closures that ensure the safety, stability, and sterility of diagnostic components. The necessity for robust IVD packaging is driven by the strict regulatory standards ensuring product integrity, preventing contamination, and addressing the complex logistics needs of transporting temperature-sensitive diagnostics. Application-wise, these packaging solutions are pivotal across hospitals, laboratories, and clinics, while the end-use scope spans pathology labs, research institutes, and academic sectors. Key growth influencers include the increasing prevalence of chronic and infectious diseases, escalated demand for point-of-care testing, and advancements in personalized medicine. Opportunities abound with the shift toward sustainable and eco-friendly packaging materials, and increased demand for innovative solutions like smart packaging that enhances product tracking and user engagement. However, stringent regulatory requirements and high costs associated with innovative packaging technologies pose significant market challenges. Furthermore, the need for cost-effective packaging solutions remains a critical limitation as pricing pressures continue to rise across healthcare systems globally. Potential areas of innovation include developing intelligent packaging that incorporates IoT and RFID technologies for improved supply chain efficiency, enhancing tamper-evidence features, and increasing the recyclability and biodegradability of materials to align with global sustainability goals. To thrive in this dynamic market, players should focus on strategic collaborations and continuous R&D to offer adaptable and compliant packaging solutions tailored to the evolving needs of the IVD industry. Conducting in-depth market research would yield competitive insights and keep businesses abreast of customer preferences and technological advancements, addressing the nature of the market that is innovation-driven but heavily regulated.

KEY MARKET STATISTICS
Base Year [2023] USD 7.24 billion
Estimated Year [2024] USD 7.70 billion
Forecast Year [2030] USD 11.44 billion
CAGR (%) 6.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Packaging Market

The In-Vitro Diagnostics Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic and infectious diseases
    • Rising trend of point-of-care testing
    • Inclination toward personalized medicine approach
  • Market Restraints
    • High cost of production of in-vitro diagnostic packaging
  • Market Opportunities
    • Introduction of smart packaging for in-vitro diagnostics
    • Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
  • Market Challenges
    • Complexity in designing in-vitro diagnostic packaging

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Packaging Market

A detailed market share analysis in the In-Vitro Diagnostics Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Packaging Market

A strategic analysis of the In-Vitro Diagnostics Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor PLC, APTARGROUP, INC., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, DWK Life Sciences GmbH, DWK Life Sciences LLC, James Alexander Corporation, Narang Medical Limited, Oliver-Tolas Healthcare Packaging B.V., PerkinElmer Inc., PMMI Media Group, QIAGEN N.V., Siemens AG, SONIC PACKAGING, Thermofisher Scientific Inc., and VITLAB GmbH.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bottles, Closures, Tubes, and Vials.
  • Based on End User, market is studied across Academic Institutes, Clinical Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious diseases
      • 5.1.1.2. Rising trend of point-of-care testing
      • 5.1.1.3. Inclination toward personalized medicine approach
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of production of in-vitro diagnostic packaging
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of smart packaging for in-vitro diagnostics
      • 5.1.3.2. Ongoing R&D for the production of sustainable in-vitro diagnostic packaging
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in designing in-vitro diagnostic packaging
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. In-Vitro Diagnostics Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Bottles
  • 6.3. Closures
  • 6.4. Tubes
  • 6.5. Vials

7. In-Vitro Diagnostics Packaging Market, by End User

  • 7.1. Introduction
  • 7.2. Academic Institutes
  • 7.3. Clinical Laboratories
  • 7.4. Hospitals

8. Americas In-Vitro Diagnostics Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor PLC
  • 2. APTARGROUP, INC.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Corning Incorporated
  • 6. DWK Life Sciences GmbH
  • 7. DWK Life Sciences LLC
  • 8. James Alexander Corporation
  • 9. Narang Medical Limited
  • 10. Oliver-Tolas Healthcare Packaging B.V.
  • 11. PerkinElmer Inc.
  • 12. PMMI Media Group
  • 13. QIAGEN N.V.
  • 14. Siemens AG
  • 15. SONIC PACKAGING
  • 16. Thermofisher Scientific Inc.
  • 17. VITLAB GmbH

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS PACKAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM IN-VITRO DIAGNOSTICS PACKAGING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. IN-VITRO DIAGNOSTICS PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. IN-VITRO DIAGNOSTICS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023